Patch clamp apply in cardiomyocytes derived from patient's iPS cells for individual anticancer therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Clinical and Experimental Medicine

• Publication date

  2014-11-15

• Fields of study

  Medicine

• Identifiers
  PMID 25550972PMCID PMC4276230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patient-Specific Induced Pluripotent Stem Cell Models

  2016cited by this paper
• ESICM 2013 - Abstracts of Oral Presentations and Poster Sessions

  2013cited by this paper
• In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes

  2012cited by this paper
• Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome

  2011cited by this paper
• Modelling the long QT syndrome with induced pluripotent stem cells

  2011cited by this paper
• Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells.

  2011cited by this paper
• Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

  2011cited by this paper
• High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

  2011cited by this paper
• Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In Vitro

  2011cited by this paper
• Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

  2011cited by this paper
• Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention

  2010cited by this paper
• Cardiovascular side-effects of modern cancer therapy.

  2010cited by this paper
• Cardiac side-effects of cancer chemotherapy.

  2010cited by this paper
• Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

  2010cited by this paper
• Progress toward the clinical application of patient-specific pluripotent stem cells.

  2010cited by this paper
• Directed Differentiation of Human‐Induced Pluripotent Stem Cells Generates Active Motor Neurons

  2009cited by this paper
• Hematopoietic Development from Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Cardiac applications for human pluripotent stem cells.

  2009cited by this paper
• Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts

  2009cited by this paper
• Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells

  2009cited by this paper
• In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes.

  2009cited by this paper
• Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells

  2009cited by this paper
• The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.

  2009cited by this paper
• Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.

  2009cited by this paper
• Cardiovascular toxicity of molecularly targeted agents.

  2009cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper

• Micro-electrode channel guide (µECG) technology: an online method for continuous electrical recording in a human beating heart-on-chip

  2021cites this paper
• Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes.

  2017cites this paper
• Stem cells - biological update and cell therapy progress

  2015cites this paper
• Gene Therapy and Stem Cells in the Treatment of Congenital Diseases

  2015cites this paper